Evidence map›Paper›PMID 34740981›Full record

ArticleOccupational and environmental medicine2022

Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities.

Jeadran Nevardo Malagón-Rojas, Marcela Mercado-Reyes, Yezith G Toloza-Pérez, Eliana L Parra Barrera, Marien Palma, Esperanza Muñoz, Ronald López, Julia Almentero, Vivian V Rubio, Edgar Ibáñez and 7 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Occupational and environmental medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Environmental Effects of the COVID-19 Pandemic: The Experience of Bogotá, 2020.International journal of environmental research and public health · 2022
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Jeadran Nevardo Malagón-RojasDoctorado en Salud Pública, El Bosque University Faculty of Medicine, Bogota, Colombia jnmalagon@unbosque.edu.co.ORCID 0000-0001-5801-936X
Marcela Mercado-ReyesResearch Directorate, National Institute of Health, Bogota, Colombia.
Yezith G Toloza-PérezGrupo de investigación en Salud Ambiental y Laboral, Instituto Nacional de Salud, Bogotá, Colombia.ORCID 0000-0001-9514-7192
Eliana L Parra BarreraGrupo de investigación en Salud Ambiental y Laboral, Instituto Nacional de Salud, Bogotá, Colombia.ORCID 0000-0002-2745-7997
Marien PalmaGrupo de investigación en Salud Ambiental y Laboral, Instituto Nacional de Salud, Bogotá, Colombia.ORCID 0000-0001-8494-7370
Esperanza MuñozFaculty of Nursing, National University of Colombia, Bogota, Colombia.
Ronald LópezGrupo de investigación en Salud Ambiental y Laboral, Instituto Nacional de Salud, Bogotá, Colombia.ORCID 0000-0001-7646-4184
Julia AlmenteroGrupo de investigación en Salud Ambiental y Laboral, Instituto Nacional de Salud, Bogotá, Colombia.ORCID 0000-0001-7203-8380
Vivian V RubioResearch Directorate, National Institute of Health, Bogota, Colombia.ORCID 0000-0002-7487-1891
Edgar IbáñezEl Bosque University Faculty of Medicine, Bogota, Colombia.
Eliana TéllezGrupo de investigación en Salud Ambiental y Laboral, Instituto Nacional de Salud, Bogotá, Colombia.ORCID 0000-0001-7421-0439
Lucy G Delgado-MurciaImmunotoxicology Research Group, National University of Colombia-Bogota, Bogota, Colombia.ORCID 0000-0003-2947-7796
Claudia P JimenezNational Open and Distance University, Bucaramanga, Colombia.
Diego Viasus-PérezSchool of Medicine, Universidad del Norte, Barranquilla, Colombia.ORCID 0000-0001-8408-3947
Marisol GalindoResearch Directorate, National Institute of Health, Bogota, Colombia.ORCID 0000-0002-3473-8703
Luisa LagosGrupo de investigación en Salud Ambiental y Laboral, Instituto Nacional de Salud, Bogotá, Colombia.ORCID 0000-0001-9714-565X
Interinstitutional Support Group
Instituto Nacional de Salud · COUniversidad Nacional de Colombia · COFundación para la Educación y el Desarrollo Social · COUniversidad El Bosque · COUniversidad del Norte · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealthcare workers are at increased risk of infection due to occupational exposure to SARS-CoV-2-infected patients. The objective of this study was to determine the seroprevalence of SARS-CoV-2 in healthcare workers in Colombia.

methodsThis study is a cross-sectional study focused on estimating the seroprevalence of SARS-CoV-2 antibodies in healthcare workers from 65 hospitals in 10 cities in Colombia during the second semester of 2020. The seroprevalence was determined using an automated immunoassay (Abbott SARS-CoV-2 CLIA IgG). The study included a survey to establish the sociodemographic variables and the risk of infection. A multivariate model was used to evaluate the association between the results of seroprevalence and risk factors.

resultsThe global seroprevalence of antibodies against SARS-CoV-2 was 35% (95% Bayesian CI 33% to 37%). All the personnel reported the use of protective equipment. General services personnel and nurses presented the highest ratios of seroprevalence among the healthcare workers. Low socioeconomic strata have shown a strong association with seropositivity.

conclusionThis study estimates the prevalence of SARS-CoV-2 infection among healthcare workers. Even though all the personnel reported the use of protective equipment, the seroprevalence in the general services personnel and nurses was high. Also, a significant difference by cities was observed.

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralBayes TheoremCitiesColombiaCross-Sectional StudiesHealth PersonnelHumansImmunoglobulin GSeroepidemiologic StudiesAntibodies, ViralImmunoglobulin GCOVID-19cross-sectional studieshealth personneloccupational healthpublic health

Identifiers

PMID34740981
PMCPMC8577941
OpenAlexW3209947947

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.